Genmab — November 2016
-
-
Børsen Play om opkøbssnakken. https://play.borsen.dk/social/583d30221f5e419167e14a1d
-
En hel række daratumumab studier opdaterede på clinicaltrials.gov pr. 25/11.https://clinicaltrials.gov/ct2/results?term=daratumumab&type=&rslt=&recr=&age_v=&gndr=&cond=&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&rcv_s=&rcv_e=&lup_s=11%2F20%2F2016&lup_e=11%2F29%2F2016
-
Tak GB.
-
-
BUZZ-Actelion: soars after J&J raises offer - Reuters News
29-Nov-2016 16:42:22
** Swiss biotech group's shares ATLN.S rise >9 pct to hit all time high in volume
** Johnson & Johnson JNJ.N is raising its offer for the company, a source says (Full Story)
** Earlier today Actelion's shares were down >5 pct after report that co was weighing a "complicated deal" with J&J (Full Story)
** Actelion now top performer and biggest boost on Stoxx 600 .STOXX index; also at the top of Swiss blue-chip index -
Actelion er nu +8% i dag. Rygter siger JNJ har forhøjet deres bud.
-
Actelion har vist en dygtig CEO
-
ACTELION HAS GIVEN J&J ACCESS TO SOME OF ITS FINANCIAL INFORMATION AS PART OF THE DEAL NEGOTIATIONS - BLOOMBERG, CITING SOURCES - Reuters News
-
JNJ har forhøjet buddet med 16%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind